The Globostad study OBS15990 Site App has been developed for the Prospective Observational Study of adult patients receiving Dupixent for atopic dermatitis.The Site App will collect eDiary information for subjects registered into this study with the data being collected during their Site visits. *Note: this App requires an activation code and can only be accessed by subjects who are participating in the OBS15990 trial